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DEFINITION OF THE DISEASE: Dominant Optic Atrophy (DOA) is a neuro-ophthalmic
condition characterized by a bilateral degeneration of the optic nerves, causing
insidious visual loss, typically starting during the first decade of life. The disease
affects primary the retinal ganglion cells (RGC) and their axons forming the optic
nerve, which transfer the visual information from the photoreceptors to the lateral
geniculus in the brain. EPIDEMIOLOGY: The prevalence of the disease varies from
1/10000 in Denmark due to a founder effect, to 1/30000 in the rest of the world.
CLINICAL DESCRIPTION: DOA patients usually suffer of moderate visual loss,
associated with central or paracentral visual field deficits and color vision defects.
The severity of the disease is highly variable, the visual acuity ranging from normal to
legal blindness. The ophthalmic examination discloses on fundoscopy isolated optic
disc pallor or atrophy, related to the RGC death. About 20% of DOA patients harbour
extraocular multi-systemic features, including neurosensory hearing loss, or less
commonly chronic progressive external ophthalmoplegia, myopathy, peripheral
neuropathy, multiple sclerosis-like illness, spastic paraplegia or cataracts.
AETIOLOGY: Two genes (OPA1, OPA3) encoding inner mitochondrial membrane
proteins and three loci (OPA4, OPA5, OPA8) are currently known for DOA. Additional
loci and genes (OPA2, OPA6 and OPA7) are responsible for X-linked or recessive optic
atrophy. All OPA genes yet identified encode mitochondrial proteins embedded in the
inner membrane and ubiquitously expressed, as are the proteins mutated in the Leber
Hereditary Optic Neuropathy. OPA1 mutations affect mitochondrial fusion, energy
metabolism, control of apoptosis, calcium clearance and maintenance of
mitochondrial genome integrity. OPA3 mutations only affect the energy metabolism
and the control of apoptosis. DIAGNOSIS: Patients are usually diagnosed during their
early childhood, because of bilateral, mild, otherwise unexplained visual loss related
to optic discs pallor or atrophy, and typically occurring in the context of a family
history of DOA. Optical Coherence Tomography further discloses non-specific
thinning of retinal nerve fiber layer, but a normal morphology of the photoreceptors
layers. Abnormal visual evoked potentials and pattern ERG may also reflect the
dysfunction of the RGCs and their axons. Molecular diagnosis is provided by the
identification of a mutation in the OPA1 gene (75% of DOA patients) or in the OPA3
gene (1% of patients). PROGNOSIS: Visual loss in DOA may progress during puberty
until adulthood, with very slow subsequent chronic progression in most of the cases.
On the opposite, in DOA patients with associated extra-ocular features, the visual loss
may be more severe over time. MANAGEMENT: To date, there is no preventative or
curative treatment in DOA; severely visually impaired patients may benefit from low
vision aids. Genetic counseling is commonly offered and patients are advised to avoid
alcohol and tobacco consumption, as well as the use of medications that may interfere
with mitochondrial metabolism. Gene and pharmacological therapies for DOA are
currently under investigation.
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